Home » Newsletters » BioWorld

BioWorld

Dec. 23, 1993

View Archived Issues

CELL THERAPEUTICS GARNERS $13.9M

SERAGEN TO LICENSE IL-2 GENE PATENTS FROM AJINOMOTO

AFFYMAX GETS PATENT ON PEPTIDE LIBRARY TECHNOLOGY

Affinity Biotech's Ibuprofen Patents Allowed

GENSIA SEEKS APPROVAL FOR GENESA

IMMUNEX SHIFTS PIXYKINE RIGHTS TO CYANAMID

INSMED PHARMACEUTICALS RAISES $1M

USDA OFFICIAL OPPOSES BAN ON GENETIC CROPS

COR, ORTHO SIGN RESEARCH PARTNERSHIP

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026